You are here
A/Professor Adam Scheinberg
A/Prof Adam Scheinberg is a paediatric rehabilitation specialist who worked in Sydney at The Children's Hospital Westmead before moving to Melbourne in 2009 as the Statewide Medical Director of the Victorian Paediatric Rehabilitation Service (VPRS) .
The VPRS provides time-limited, goal-focused services to children and adolescents following illness or injury. It is one of the largest paediatric rehabilitation services in Australia with eight sites around Victoria. As the medical director, Associate Professor Scheinberg is involved in ensuring best practice treatment and translation of clinical research into services provided by the VPRS.
A/Prof Scheinberg is the immediate past president of the Australasian Academy of Cerebral Palsy and Developmental Medicine (AusACPDM) and has been on the scientific and organising committees for most of the academy's biennial conferences. He is on the Paediatric Rehabilitation Training Committee and teaches and examines for the Australasian Faculty of Rehabilitation Medicine.
- Statewide Medical Director, Victorian Paediatric Rehabilitation Service
- Head of Department Rehabilitation, Royal Children's Hospital
- Associate Professor, Department Medicine, Monash University
A/Prof Scheinberg's research focus has been on the management of childhood disability, specifically focused on cerebral palsy, acquired brain injury, and spinal cord injury. Many of his publications relate to interventions for spasticity and other movement disorders in children with cerebral palsy, including treatments such as Botulinum toxin, intrathecal baclofen infusion and oral baclofen.
He has an interest in program development and has published on how rehabilitation teams function to improve patient care and safety. More recently he has been involved in development of Chronic Fatigue Syndrome services in Victoria and has developed a research program embedded within the clinical service.
- Does benzhexol hydrochloride reduce dystonia in children with cerebral palsy?
- Development of a comprehensive assessment system and best practice management for children and adolescents with Chronic Fatigue Syndrome.
- APSU study of prevalence of Chronic Fatigue Syndrome in Australia.
- Cochrane systematic review N0018. Trihexyphenidyl for dystonia in cerebral palsy
- Making connections: using expert perspectives to guide the establishment of a national paediatric spinal cord injury database.
Sarah Knight, Adrienne Harvey, Susan Towns, Donald Payne, Lionel Lubitz, Kathy Rowe, Colette Reveley, Sabine Hennel and Adam Scheinberg. How is Paediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed and Managed by Paediatricians? An Australian National Study. J Paeds Child Health 2014; doi10.1111/jpc.12677.
Knight, S., Harvey, A., Lubitz, L., Rowe, K., Reveley, C., Veit, F., Hennel, S. and Scheinberg, A. 'Paediatric chronic fatigue syndrome: complex presentations and protracted time to diagnosis', Journal of Paediatrics and Child Health 2013; vol.49(11), pp.919-24
Jane Galvin , Adam Scheinberg , and Peter New. A Retrospective Case Series of Pediatric Spinal Cord Injury and Disease in Victoria, Australia SPINE Volume 38, Number 14, pp E878-E882
Knight S, Scheinberg A, Harvey A. Interventions in Pediatric Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review. Journal of Adolescent Health 53 (2013), pp. 154-165 DOI information: 10.1016/j.jadohealth.2013.03.009
Scheinberg AM. Commentary: Screening for children born extremely preterm and extremely low birth-weight – a role for health-related quality of life measures? Developmental Medicine & Child Neurology 2011; vol.53(10), pp.878-80
Morrow AM, Hayen A, Quine S, Scheinberg A, Craig JC. A comparison of doctors', parents' and children's reports of health states and health-related quality of life in children with chronic conditions. Child Care Health Dev. 2011 Jun 8. doi: 10.1111/j.1365-2214.2011.01240.x. [Epub ahead of print]
Alhusani A, Crosbie J, Shepherd R, Dean C, Scheinberg A. No change in passive muscle stiffness following Botulinum toxin injection to the calf in children with cerebral palsy. Dev Med Child Neurol. 2011,53:553-558
O'Flaherty S J, Janakan V, Morrow A, F, Scheinberg A, Waugh M. Botulinum Toxin Adverse Events and Health Status in children with Cerebral Palsy in all GMFCS levels. Dev Med Child Neurol. 2011,53:125-130
Burns J. Scheinberg A. Ryan MM. Rose KJ. Ouvrier RA. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric CMT1A. Muscle & Nerve 2010;42(2): 262-267.
Snyman N, Gilles J, Egan J, Giles R, Scheinberg A. The effect of zolpidem on the level of consciousness in children with severe acquired brain injury. Neuropediatrics 2010;41:223-27
Alhusani A, Crosbie J, Shepherd R, Dean C, Scheinberg A. Passive mechanical properties of the calf muscles in children with cerebral palsy compared to healthy children. Dev Med Child Neurol. 2010 Jun;52(6):e101-6. Epub 2010 Jan 28.